Sharemaestro company-news research for Siemens Healthineers AG (SHL), showing current tone, evidence confidence, direct company coverage, sector and industry context, completed price response and the source headlines used on the page. Scores describe published news evidence. Confidence describes the amount, freshness, source breadth and direct company relevance of that evidence. Price context is shown separately.
VIE
Austria
Insufficient evidence
Company news sentiment
Latest SHL news and sentiment
Siemens Healthineers AG
Company headlines from the last 30 days, weighted by freshness, relevance, publisher quality and the strength of the wording. Price is shown separately.
Current company news
No current company-news score
No company-specific headline in the last 30 days currently passes the date and relevance checks. The dash means no score; it is not a neutral observation.
Observed headline tone50/100
→
Published 30-day score50/100
Latest source headline
How Siemens Healthineers is helping its international staff feel at home
finance.yahoo.com · 08 Oct 2026 04:33
Older, less relevant and less reliable stories count for less. Confidence is shown separately.
Available information
6 current stories are mapped specifically to SHL.
Why there is no score
The stories agree, but freshness-weighted evidence is only 0.000.
Confidence is 0/100, below the threshold for a firm score.
—/100
News scoreNo qualifying directional evidence
0/100
Confidencethin evidence
0%/100
Company news6 company stories
100/100
Story agreement0/100 difference
News history
Daily score and story count over 30 days
10 Sep25 Sep09 Oct
News scoreStory count50 baseline
Confidence
How reliable the score is
Confidence uses the amount of news, separate publishers, direct company relevance, freshness and agreement. A high or low score is not automatically reliable.
Amount of evidence0
0.0 after freshness weightingSource breadth0
0 independent publishersCompany relevance0
share tied directly to this companyFreshness74
recency-weighted evidenceAgreement100
how closely stories agreePublisher mix0
less reliance on one publisherPrice and news history
Weekly price and news-score history
No sufficiently fresh, directly relevant company news is available for a price comparison.
26 completed price weeks15 comparable news-score weeks
One scoring method across the chart.Stored company headlines are recalculated at each weekly point with the current 30-day freshness weighting. Old published snapshots are left unchanged.
10 Apr07 Jul02 Oct
Weekly close, indexedSentiment score
WeekNews scoreCloseWeekly move
02 Oct 202650EUR 37.990002+0.7%
25 Sep 202650EUR 37.720001-0.8%
18 Sep 202650EUR 38.040001-1.2%
11 Sep 202650EUR 38.52-1.3%
04 Sep 202650EUR 39.040001-1.2%
28 Aug 202650EUR 39.52-0.5%
21 Aug 202650EUR 39.700001+0.5%
14 Aug 202651EUR 39.509998+0.4%
Insufficient evidence
News subjects
What is shaping the score
Market update506 stories · 100%
Source mix
Where the evidence comes from
AD HOC NEWS503 stories · 50%
finance.yahoo.com501 stories · 17%
Simply Wall St.501 stories · 17%
GlobeNewswire501 stories · 17%
Recurring subjects
Subjects appearing most often
Healthcare2Diagnostics2Share Price1Revenue Growth1Non Invasive Testing1Liver Disease1Chronic Disease Management1AI1
Earlier readings
How the score has changed
Past and present use the same method.Each point recalculates the previous 30 days of stored company headlines with today's scoring rules. The original stored snapshots remain unchanged.
26 Jun50 neutral08 Oct 09:21
ConstructiveBalanced or withheldCautious
Changes in the stored score
Scores are rebuilt from stored headlines with the current 30-day method. Days with no change are collapsed.
| Observed | Score | Move | Confidence | Stories | Status |
|---|---|---|---|---|---|
| 08 Oct 09:21 | 50 | +0 | 0/100 (0) | 6 (+1) | Insufficient |
| 02 Oct 23:59 | 50 | +0 | 0/100 (0) | 5 (-2) | Insufficient |
| 23 Sep 23:59 | 50 | +0 | 0/100 (0) | 7 (0) | Insufficient |
| 21 Sep 23:59 | 50 | +0 | 0/100 (0) | 7 (+2) | Insufficient |
| 19 Sep 23:59 | 50 | +0 | 0/100 (-14) | 5 (-4) | Insufficient |
| 01 Sep 23:59 | 50 | +0 | 14/100 (-1) | 9 (-1) | Provisional |
| 30 Aug 23:59 | 50 | +0 | 15/100 (0) | 10 (-1) | Provisional |
| 29 Aug 23:59 | 50 | +0 | 15/100 (-1) | 11 (0) | Provisional |
Evidence behind the direction
What drives this reading?
Shares of weighted directional evidence in 6 retained current headlines. These weights already account for freshness, relevance and publisher limits; they are not additive points of the published score.
No directional evidence to attribute yet
Company news can still be read below. Influence bars appear when a current story qualifies for the directional score.
Source headlines
The news behind the score
Only company-specific stories enter this score. The latest 30 days are shown newest first, with newer stories weighted more heavily and duplicate coverage combined.
—Unscored
Market updateNot used in direction
How Siemens Healthineers is helping its international staff feel at home
Relocating for work can bring a lot of additional stress. Alongside learning the requirements of a new role and meeting new colleagues, those moving internationally must also adapt to a new culture and potentially learn a new language. It's a challenge many people now face. Some 12.9 mill…
Company news retained for context; no directional weight.
Scoring detailsDirect company coverage
Relocating for work can bring a lot of additional stress. Alongside learning the requirements of a new role and meeting new colleagues, those moving internationally must also adapt to a new culture and potentially learn a new language. It's a challenge many people now face. Some 12.9 million people from outside the EU are employed in the EU labor market, according to data from the European Commission. However, expats are not always made to feel welcome. European countries were consistently ranked among the worst countries for expats, according to InterNations' Expat Insider 2026 report, with m
- Published
- 08 Oct 2026 04:33
- News subject
- Market update
- Why this score
- No clear directional signal in the available text
- Company focus
- Shared story · 78%
- How it is used
- Shown as company news · not used in the score
- Story strength
- Not directional
- 30-day weight
- None · 1.0d old
- Text assessed
- Available headline and article text
- Duplicates
- 1 consolidated
—Unscored
Market updateNot used in direction
JPMorgan setzt Ziel für Siemens-Healthineers-Aktie auf 57,40 Euro
Company news retained for context; no directional weight.
Scoring detailsDirect company coverage
- Published
- 02 Oct 2026 09:51
- News subject
- Market update
- Why this score
- No clear directional signal in the available text
- Company focus
- Main company · 100%
- How it is used
- Shown as company news · not used in the score
- Story strength
- Not directional
- 30-day weight
- None · 6.8d old
- Text assessed
- Available headline and article text
- Duplicates
- 1 consolidated
—Unscored
Market updateNot used in direction
What Does Siemens Healthineers (XTRA:SHL) New Liver Disease Collaboration Mean?
Siemens Healthineers (XTRA:SHL) and Novo announced a new collaboration to address MASLD and MASH using non-invasive diagnostics. The partnership focuses on expanding disease awareness and clinical use of less invasive tools for assessing liver health and progression risk. Both groups aim …
Company news retained for context; no directional weight.
Scoring detailsDirect company coverage
Siemens Healthineers (XTRA:SHL) and Novo announced a new collaboration to address MASLD and MASH using non-invasive diagnostics. The partnership focuses on expanding disease awareness and clinical use of less invasive tools for assessing liver health and progression risk. Both groups aim to support earlier identification of at-risk patients, potentially affecting how metabolic liver conditions are managed in routine care. The Siemens Healthineers and Novo MASLD and MASH collaboration is worth weighing alongside the rest of our findings on SHL. Our analysis turns up 1 warning sign for Siemens H
- Published
- 23 Sep 2026 15:17
- News subject
- Market update
- Why this score
- Strategic partnership
- Company focus
- Shared story · 78%
- How it is used
- Shown as company news · not used in the score
- Story strength
- Not directional
- 30-day weight
- None · 15.6d old
- Text assessed
- Stored article
- Duplicates
- 1 consolidated
AIChronic Disease ManagementDiagnosticsHealthcareRevenue GrowthShare Price
—Unscored
Market updateNot used in direction
Siemens Healthineers and Novo Join Forces to Advance Care for People Living with MASLD and MASH
SH Logo Tarrytown, New York, USA, Sept. 21, 2026 (GLOBE NEWSWIRE) -- People most at risk for MASLD/MASH remain largely unaware of the disease and its wider health risks Patients facing this metabolic condition benefit from early intervention The companies aim to remove barriers to non-inv…
Company news retained for context; no directional weight.
Scoring detailsDirect company coverage
SH Logo Tarrytown, New York, USA, Sept. 21, 2026 (GLOBE NEWSWIRE) -- People most at risk for MASLD/MASH remain largely unaware of the disease and its wider health risks Patients facing this metabolic condition benefit from early intervention The companies aim to remove barriers to non-invasive testing Siemens Healthineers and Novo have announced a collaboration focused on advancing care for people living with metabolic dysfunction-associated steatotic liver disease (MASLD) and its progressive form, metabolic dysfunction-associated steatohepatitis (MASH). The companies are engaged in several pr
- Published
- 21 Sep 2026 14:45
- News subject
- Market update
- Why this score
- Strategic partnership
- Company focus
- Shared story · 78%
- How it is used
- Shown as company news · not used in the score
- Story strength
- Not directional
- 30-day weight
- None · 17.6d old
- Text assessed
- Stored article
- Duplicates
- 1 consolidated
DiagnosticsHealthcareLiver DiseaseNon Invasive Testing
—Unscored
Market updateNot used in direction
Die Siemens-Healthineers-Aktie reagiert auf angepasste Umsatz- und Gewinnprognose
Company news retained for context; no directional weight.
Scoring detailsDirect company coverage
- Published
- 21 Sep 2026 12:18
- News subject
- Market update
- Why this score
- No clear directional signal in the available text
- Company focus
- Main company · 100%
- How it is used
- Shown as company news · not used in the score
- Story strength
- Not directional
- 30-day weight
- None · 17.7d old
- Text assessed
- Stored headline only
- Duplicates
- 1 consolidated
—Unscored
Market updateNot used in direction
Die Siemens-Healthineers-Aktie zeigt stabile Kursentwicklung nach soliden Quartalszahlen
Company news retained for context; no directional weight.
Scoring detailsDirect company coverage
- Published
- 19 Sep 2026 09:30
- News subject
- Market update
- Why this score
- No clear directional signal in the available text
- Company focus
- Main company · 100%
- How it is used
- Shown as company news · not used in the score
- Story strength
- Not directional
- 30-day weight
- None · 19.8d old
- Text assessed
- Stored headline only
- Duplicates
- 1 consolidated
Earlier company news
SHL news archive
Stored newest first for historical research. It starts after the newest three pages above and then continues through older news. Each archive page is loaded only when it is opened.
Older news is kept in the archive
There are 16 older SHL headlines. Open one page at a time when you need them.
Open older archiveProvider matches checked
Provider mentions not used in the score
A news provider linked these stories to SHL, but the headline and available text are not mainly about Siemens Healthineers AG. They are kept here for transparency and do not affect the score, confidence, history or wider market totals.
Provider mentions are kept separate
Open the list to see which provider matches were checked and left out of SHL sentiment.
Open provider mentionsHow the page works
How to read the score
It describes the weighted balance of qualifying headlines. A score of 50 can mean balanced news or that there is not enough evidence; the status label explains which.
Confidence measures depth, source breadth, direct relevance, freshness and agreement. It does not rise merely because the tone is extreme. This is a rule-based evidence measure, not a calibrated probability.
Weekly price response, trend and fair-value position test whether the market is accepting or rejecting the news. They never rewrite the news score.
It measures news already published. It is not a forecast, recommendation or price target.